Safety and Feasibility Update of Olaparib, an Orally Bioavailable PARP Inhibitor, With Concurrent Cetuximab and Radiation Therapy in Heavy Smokers With Stage III-IVB Squamous Cell Carcinoma of the Head/Neck: A Phase 1 Trial

Preliminary Safety and Tolerability of a Phase 1 Trial of Olaparib in Combination With Cetuximab and Radiation Therapy in Heavy Smokers With Locally Advanced, Stage IVA-B Squamous Cell Carcinoma of the Head/Neck

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.11.169 ◽

2014 ◽

Vol 88 (2) ◽

pp. 517-518

Author(s):

T. Waxweiler ◽

D. Bowles ◽

K. Reddy ◽

P. Blatchford ◽

J.I. Song ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Phase 1 ◽

Locally Advanced ◽

Advanced Stage ◽

Phase 1 Trial ◽

Head Neck ◽

Heavy Smokers

1044 The prophylactic use of pentoxifylline in the therapy of stage IV-N2—3 head & neck (H/N) squamous cell carcinoma (SCCa) treated with supradose intraarterial targeted fcisplatin (SIT-P) and concurrent radiation therapy (RT): preliminary results of a pilot study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(99)90270-5 ◽

1999 ◽

Vol 45 (3) ◽

pp. 279 ◽

Author(s):

P. Kumar ◽

J. Wan ◽

F. Viera ◽

F.S. Wong ◽

K.T. Robbins

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Pilot Study ◽

Cell Carcinoma ◽

Squamous Cell ◽

Stage Iv ◽

Preliminary Results ◽

Prophylactic Use ◽

Head Neck

A Phase 1 Trial of Pazopanib Added to Cetuximab in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.12.031 ◽

2016 ◽

Vol 94 (4) ◽

pp. 868 ◽

Cited By ~ 2

Author(s):

D. Adkins ◽

J. Ley ◽

T. Wildes ◽

K. Trinkaus ◽

M. Siegel ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase 1 ◽

Phase 1 Trial

Mature results of Radiation Therapy Oncology Group (RTOG) Trial 9615 using intra-arterial cisplatin (IA-P) and concurrent radiation therapy (RT) for stage IV-T4 head/neck (H/N) squamous cell carcinoma (SCCa)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.5579 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5579-5579 ◽

Cited By ~ 2

Author(s):

P. Kumar ◽

K. T. Robbins ◽

J. Harris ◽

T. McCulloch ◽

A. Cmelak ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Radiation Therapy Oncology Group ◽

Stage Iv ◽

Oncology Group ◽

Head Neck

A phase 1 trial of vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced stage head and neck squamous cell carcinoma.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.6036 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 6036-6036 ◽

Author(s):

Theodoros Nicholas Teknos ◽

Matthew Owen Old ◽

John C. Grecula ◽

Amit Agrawal ◽

Enver Ozer ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase 1 ◽

Chemoradiation Therapy ◽

Advanced Stage ◽

Phase 1 Trial ◽

Concurrent Chemoradiation Therapy

A Phase 1 Trial of Ketogenic Diet With Concurrent Chemoradiation (CRT) in Head and Neck Squamous Cell Carcinoma (HNSCC)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.12.104 ◽

2016 ◽

Vol 94 (4) ◽

pp. 898 ◽

Author(s):

C.M. Anderson ◽

E. Loth ◽

E. Opat ◽

K. Bodeker ◽

L. Ahmann ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Ketogenic Diet ◽

Squamous Cell ◽

Phase 1 ◽

Concurrent Chemoradiation ◽

Phase 1 Trial

Phase 1 trial of adavosertib (AZD1775) in combination with concurrent radiation and cisplatin for intermediate‐risk and high‐risk head and neck squamous cell carcinoma

Cancer ◽

10.1002/cncr.33789 ◽

2021 ◽

Author(s):

Bhishamjit S. Chera ◽

Siddharth H. Sheth ◽

Shetal A. Patel ◽

Dan Goldin ◽

Kathe E. Douglas ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

High Risk ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase 1 ◽

Intermediate Risk ◽

Phase 1 Trial

Phase 1 Trial of Bevacizumab With Concurrent Chemoradiation Therapy for Squamous Cell Carcinoma of the Head and Neck With Exploratory Functional Imaging of Tumor Hypoxia, Proliferation, and Perfusion

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.11.029 ◽

2015 ◽

Vol 91 (5) ◽

pp. 942-951 ◽

Cited By ~ 26

Author(s):

Matthew J. Nyflot ◽

Tim J. Kruser ◽

Anne M. Traynor ◽

Deepak Khuntia ◽

David T. Yang ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Functional Imaging ◽

Squamous Cell ◽

Phase 1 ◽

Tumor Hypoxia ◽

Chemoradiation Therapy ◽

Phase 1 Trial ◽

Concurrent Chemoradiation Therapy

A phase 1 trial of Vorinostat in combination with concurrent chemoradiation therapy in the treatment of advanced staged head and neck squamous cell carcinoma

Investigational New Drugs ◽

10.1007/s10637-018-0696-4 ◽

2018 ◽

Vol 37 (4) ◽

pp. 702-710 ◽

Cited By ~ 4

Author(s):

Theodoros N. Teknos ◽

J. Grecula ◽

A. Agrawal ◽

M. O. Old ◽

E. Ozer ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase 1 ◽

Chemoradiation Therapy ◽

Concurrent Chemoradiation ◽

Phase 1 Trial ◽

Concurrent Chemoradiation Therapy

The feasibility of using intra-arterial cisplatin & radiation therapy for stage IV-T4 head/neck (H/N) squamous cell carcinoma in a multi-institutional setting: preliminary results of radiation therapy oncology group (RTOG) trial 9615

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(00)80098-x ◽

2000 ◽

Vol 48 (3) ◽

pp. 152 ◽

Author(s):

P Kumar ◽

J Harris ◽

K.T Robbins ◽

P Levine ◽

T McCulloch ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Squamous Cell ◽

Radiation Therapy Oncology Group ◽

Stage Iv ◽

Institutional Setting ◽

Oncology Group ◽

Preliminary Results ◽

Head Neck